Nomura (NMR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $9.28, +0.22% vs the prior close of $9.26.
- Volume 717.80K shares, 1.0x its 50-day average.
- New SEC filings: 424B2 (Oct 16, 2026), 424B2 (Oct 15, 2026), 424B2 (Oct 15, 2026), 424B2 (Oct 14, 2026), 424B2 (Oct 14, 2026), 6-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
NMR ends flat (+0.2%) to $9.28. Closed at $9.28, +0.22% vs the prior close of $9.26. Day range $9.14–$9.29, opened at $9.19.
NMR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NMR ends flat (+0.2%) to $9.28
- Closed at $9.28, +0.22% vs the prior close of $9.26. Day range $9.14–$9.29, opened at $9.19.
- Volume was 717.80K shares, 1.0x its 50-day average of 684.30K.
- Price is -7.0% vs its 50-day average ($9.97) and +3.3% vs its 200-day average ($8.98).
- 52-week range $6.88–$10.94; today's close sits at 59% of that range, 15.2% below the 52-week high.
Oct 14, 2026 — NMR slides 3.3% to $9.26, a 3-month low
- Closed at $9.26, -3.34% vs the prior close of $9.58. Day range $9.00–$9.31, opened at $9.29.
- Volume was 725.80K shares, 1.1x its 50-day average of 687.16K.
- Price is -7.3% vs its 50-day average ($9.99) and +3.1% vs its 200-day average ($8.98).
- 52-week range $6.78–$10.94; today's close sits at 60% of that range, 15.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 13, 2026 — NMR ends flat (+0.1%) to $9.58
- Closed at $9.58, +0.10% vs the prior close of $9.57. Day range $9.53–$9.72, opened at $9.68.
- Volume was 686.80K shares, 1.0x its 50-day average of 694.20K.
- Price is -4.2% vs its 50-day average ($10.00) and +6.7% vs its 200-day average ($8.98).
- 52-week range $6.75–$10.94; today's close sits at 68% of that range, 12.4% below the 52-week high.
Oct 12, 2026 — NMR ends flat (-0.2%) to $9.57
- Closed at $9.57, -0.21% vs the prior close of $9.59. Day range $9.54–$9.66, opened at $9.61.
- Volume was 774.30K shares, 1.1x its 50-day average of 695.90K.
- Price is -4.3% vs its 50-day average ($10.00) and +6.7% vs its 200-day average ($8.97).
- 52-week range $6.71–$10.94; today's close sits at 68% of that range, 12.5% below the 52-week high.
Oct 9, 2026 — NMR rises 0.5% to $9.59
- Closed at $9.59, +0.52% vs the prior close of $9.54. Day range $9.44–$9.62, opened at $9.48.
- Volume was 594.20K shares, 0.8x its 50-day average of 723.32K.
- Price is -4.1% vs its 50-day average ($10.00) and +7.0% vs its 200-day average ($8.96).
- 52-week range $6.71–$10.94; today's close sits at 68% of that range, 12.3% below the 52-week high.
Oct 8, 2026 — NMR ends flat (+0.1%) to $9.54
- Closed at $9.54, +0.10% vs the prior close of $9.53. Day range $9.35–$9.55, opened at $9.45.
- Volume was 782.50K shares, 1.1x its 50-day average of 739.88K.
- Price is -4.6% vs its 50-day average ($10.00) and +6.5% vs its 200-day average ($8.96).
- 52-week range $6.71–$10.94; today's close sits at 67% of that range, 12.8% below the 52-week high.
Oct 7, 2026 — NMR dips 2.6% to $9.53, a 1-month low
- Closed at $9.53, -2.56% vs the prior close of $9.78. Day range $9.44–$9.58, opened at $9.58.
- Volume was 729.60K shares, 1.0x its 50-day average of 745.22K.
- Price is -4.7% vs its 50-day average ($10.00) and +6.5% vs its 200-day average ($8.95).
- 52-week range $6.71–$10.94; today's close sits at 67% of that range, 12.9% below the 52-week high.
Oct 6, 2026 — NMR rises 0.3% to $9.78
- Closed at $9.78, +0.31% vs the prior close of $9.75. Day range $9.69–$9.83, opened at $9.80.
- Volume was 567.90K shares, 0.8x its 50-day average of 749.01K.
- Price is -2.2% vs its 50-day average ($10.00) and +9.3% vs its 200-day average ($8.94).
- 52-week range $6.71–$10.94; today's close sits at 73% of that range, 10.6% below the 52-week high.
Oct 5, 2026 — NMR ends flat (+0.2%) to $9.75
- Closed at $9.75, +0.21% vs the prior close of $9.73. Day range $9.66–$9.81, opened at $9.70.
- Volume was 585.60K shares, 0.8x its 50-day average of 751.20K.
- Price is -2.5% vs its 50-day average ($10.00) and +9.1% vs its 200-day average ($8.94).
- 52-week range $6.71–$10.94; today's close sits at 72% of that range, 10.9% below the 52-week high.
Oct 2, 2026 — NMR ends flat (-0.1%) to $9.73, a 1-month low, 5 down days in a row
- Closed at $9.73, -0.10% vs the prior close of $9.74. Day range $9.64–$9.75, opened at $9.67.
- Volume was 886.20K shares, 1.2x its 50-day average of 747.62K.
- Price is -2.7% vs its 50-day average ($10.00) and +9.0% vs its 200-day average ($8.93).
- 52-week range $6.71–$10.94; today's close sits at 71% of that range, 11.1% below the 52-week high.
- That makes 5 straight losses.
NMR latest news & SEC filings
Every SEC filing by or about NMR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 15, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 15, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 14, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 14, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 9, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 9, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 8, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade NMR
- How much it moves: over the last 20 sessions the average daily move was 0.99% (largest 3.3%). That is a relatively calm stock.
- Liquidity: about 674.67K shares (≈$6.26M) trade per day on average.
- 52-week position: $9.28 vs a range of $6.88–$10.94 (59% of the range).
- Dividends: last ex-dividend date Mar 31, 2025 ($0.238/share); 0 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 0 sales; latest: Masahiro Ishizuka bought 238 shares on Mar 25, 2026.
- Latest filings: 6-K Oct 14, 2026; 6-K Sep 17, 2026; 6-K Sep 14, 2026.
- Listing: NYSE · industry: Security Brokers, Dealers & Flotation Companies.
NMR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 9.19 | 9.29 | 9.14 | 9.28 | 717.80K |
| Oct 14, 2026 | 9.29 | 9.31 | 9.00 | 9.26 | 725.80K |
| Oct 13, 2026 | 9.68 | 9.72 | 9.53 | 9.58 | 686.80K |
| Oct 12, 2026 | 9.61 | 9.66 | 9.54 | 9.57 | 774.30K |
| Oct 9, 2026 | 9.48 | 9.62 | 9.44 | 9.59 | 594.20K |
| Oct 8, 2026 | 9.45 | 9.55 | 9.35 | 9.54 | 782.50K |
| Oct 7, 2026 | 9.58 | 9.58 | 9.44 | 9.53 | 729.60K |
| Oct 6, 2026 | 9.80 | 9.83 | 9.69 | 9.78 | 567.90K |
| Oct 5, 2026 | 9.70 | 9.81 | 9.66 | 9.75 | 585.60K |
| Oct 2, 2026 | 9.67 | 9.75 | 9.64 | 9.73 | 886.20K |
| Oct 1, 2026 | 9.73 | 9.80 | 9.55 | 9.74 | 767.10K |
| Sep 30, 2026 | 9.92 | 9.93 | 9.77 | 9.78 | 484.70K |
| Sep 29, 2026 | 9.94 | 9.94 | 9.80 | 9.91 | 549.90K |
| Sep 28, 2026 | 10.03 | 10.14 | 10.01 | 10.02 | 623.50K |
| Sep 25, 2026 | 10.00 | 10.09 | 9.96 | 10.06 | 591.10K |
| Sep 24, 2026 | 9.77 | 9.78 | 9.66 | 9.77 | 1.24M |
| Sep 23, 2026 | 9.88 | 10.06 | 9.82 | 9.84 | 661.00K |
| Sep 22, 2026 | 10.15 | 10.23 | 9.94 | 9.96 | 601.30K |
| Sep 21, 2026 | 10.18 | 10.21 | 10.10 | 10.14 | 375.00K |
| Sep 18, 2026 | 10.14 | 10.14 | 9.96 | 10.07 | 550.00K |
About Nomura
Nomura (NMR) is listed on the NYSE and classified by the SEC under “Security Brokers, Dealers & Flotation Companies”. Its business address is in TOKYO. State of incorporation: Japan. Fiscal year ends March 31. SEC CIK 1163653.
NMR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lap Lik Victor Chu | Director | Mar 18, 2026 |
| James Christopher Giancarlo | Director | Mar 18, 2026 |
| Miyuki Ishiguro | Director | Mar 18, 2026 |
| Masahiro Ishizuka | Director | Sep 28, 2026 |
| Jean Nelly Liang | Director | Mar 18, 2026 |
| Patricia Campbell Mosser | Director | Mar 18, 2026 |
| Koji Nagai | Director | Jun 29, 2026 |
| Shoji Ogawa | Director | Sep 28, 2026 |
| Kentaro Okuda | See Remarks | May 27, 2026 |
| Taku Oshima | Director | Mar 18, 2026 |
| Takahisa Takahara | Director | Jun 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Patrick James Eltridge | See Remarks | Mar 18, 2026 |
| Masahiro Goto | See Remarks | May 27, 2026 |
| Akio Hori | See Remarks | Sep 28, 2026 |
| Yuko Horiuchi | See Remarks | May 27, 2026 |
| Toshiyasu Iiyama | See Remarks | May 27, 2026 |
| Sotaro Kato | See Remarks | May 27, 2026 |
| Yoshifumi Kishida | See Remarks | Mar 18, 2026 |
| Takumi Kitamura | See Remarks | May 27, 2026 |
| Hiroyasu Koike | See Remarks | Sep 28, 2026 |
| Naotaka Minami | See Remarks | May 27, 2026 |
| Shinichi Mizuno | See Remarks | Mar 18, 2026 |
| Takako Mori | See Remarks | May 27, 2026 |
| Hiroyuki Moriuchi | See Remarks | May 27, 2026 |
| Yutaka Nakajima | See Remarks | May 27, 2026 |
| Yoshihiro Namura | See Remarks | Mar 18, 2026 |
| Shinichi Okada | See Remarks | Mar 18, 2026 |
| Kentaro Okuda | See Remarks | May 27, 2026 |
| Yukiko Ozaki | See Remarks | Sep 28, 2026 |
| Go Sugiyama | See Remarks | May 27, 2026 |
| Akihito Tobari | See Remarks | Sep 28, 2026 |
| Christopher Paul Willcox | See Remarks | May 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 25, 2026 | Masahiro Ishizuka | Buy | 238 | $8.05 |
| Mar 25, 2026 | Shoji Ogawa | Buy | 238 | $8.05 |
| Mar 25, 2026 | Yukiko Ozaki | Buy | 8 | $8.05 |
NMR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NMR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Security Brokers, Dealers & Flotation Companies
Robinhood Markets (HOOD)Goldman Sachs (GS)Morgan Stanley (MS)Schwab Charles (SCHW)BlackRock (BLK)Interactive Brokers (IBKR)Xp (XP)Raymond James Financial (RJF)Marketaxess (MKTX)Futu (FUTU)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NMR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.